Documents
Access a comprehensive collection of resources, including brochures, infographics, user manuals, validation data, technical notes, and white papers. Easily filter by document type, application, research area, and products to find the specific information you need.
Filters
| Documents | Document type | Application | Research area | Product |
|---|---|---|---|---|
General Terms and Conditions for Purchase of Goods and Services This document describes the terms and conditions that applies for all purchases made by Olink. | ||||
General Terms and Conditions for Purchase of Instruments and kits for EMEA and ROW For use when purchasing kits and/or Olink® Signature Q100, or other instruments and consumables, from Olink Proteomics AB and buying entity is located outside US and North America. | ||||
General Terms and Conditions for Purchase of Instruments and Kits in Japan For use when purchasing kits and/or Signature Q100, or other instruments and consumables, from Olink Proteomics AB and buying entity is located in Japan. | ||||
General Terms and Conditions for Purchase of Instruments and Kits in North America For use when purchasing kits and/or Signature Q100, or other instruments and consumables, from Olink Proteomics Inc and buying entity is located in US or North America. | ||||
High consistency between qPCR readout instruments for Olink® data technical note | ||||
Insights from precious samples in inflammatory and infectious disease research | ||||
Insights from precious samples in metabolomic and cardiovascular disease research | ||||
Insights from precious samples in neurology research | ||||
Insights from precious samples in oncology research | ||||
Insights into cytokine storm research with circulating biomarkers (short) | ||||
Introducing Olink® Flex: Immuno-Oncology panel | ||||
Introducing Olink® Flex: Interferon Stimulation Panel | ||||
Introducing Olink® Flex: Th1/Th2/Th17 Panel | ||||
It's all relative - 4 reasons with biomarker discovery commonly uses relative quantification Absolute and relative quantification are performed in proteomics to identify and validate protein biomarkers for clinical applications. In this white paper, four reasons why relative quantification remains the prevalent method for biomarker discovery are provided. Moreover, multiplex proteomic platforms from Olink® that offer both absolute and relative quantification options are described. | ||||
NovaSeq 6000 SP vs S1 flow cell comparison technical note | ||||
NovaSeq™ 6000 SP vs S4 flow cell comparison technical note | ||||
NPX™ Explore HT & 3072 Software User Manual | ||||
NPX™ Map CLI Technology Information | ||||
NPX™ Map Software User Manual | ||||
NPX™ Signature for Olink® Flex User Manual This manual includes instructions for old version (v 1.x) of the NPX™ Signature Software. |